Helus Pharma Inc.
HELP | NASDAQ
$8.79
-$1.81 (-17.04%)
Nov 2, 2026, 11:21 AM ET · Market open
Fiscal Year Period Ending | FY 2026 Mar 31, 2026 | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 | FY 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|
PE Ratio | -1.13 | -1.52 | -2.04 | -0.82 | -0.48 | -0.61 |
PEG Ratio | 0.05 | -0.04 | 0.03 | 0.02 | -0.02 | 0 |
PS Ratio | -3.74 | 364.06 | n/a | 155.28 | 193.91 | 22.62 |
PB Ratio | 0.72 | 0.72 | 0.55 | 0.81 | 0.43 | 0.23 |
P/FCF Ratio | -1.25 | -1.66 | -2.30 | -0.77 | -0.71 | -1.01 |
P/OCF Ratio | -1.26 | -1.70 | -2.32 | -0.82 | -0.72 | -1.03 |
OCF/S Ratio | 296.35 | -21.45K | n/a | -18.9K | -26.95K | -2.2K |
Debt / Equity Ratio | n/a | n/a | 0 | n/a | n/a | n/a |
Quick Ratio | 9.52 | 7.75 | 21.65 | 4.09 | 7.38 | 13.57 |
Current Ratio | 9.52 | 7.75 | 21.65 | 4.09 | 7.38 | 13.57 |
Asset Turnover | -0.18 | 0 | n/a | 0 | 0 | 0.01 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | -3.1K |
Return on Equity | -63.32% | -47.70% | -26.75% | -98.46% | -88.81% | -37.41% |
Return on Assets | -58.36% | -43.75% | -25.85% | -88.11% | -80.45% | -34.98% |
Return on Invested Capital | -60.93% | -60.10% | -26.98% | -106.25% | -83.62% | -35.59% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 100.27% | n/a | n/a | n/a | n/a | -36% |
Net Profit Margin | 329.09% | -23.96K% | n/a | -18.92K% | -40.31K% | -3.73K% |
Pretax Profit Margin | 129.09% | -24.06K% | n/a | -19.02K% | -40.41K% | -3.73K% |
Operating Profit Margin | 317.06% | -30.31K% | n/a | -20.52K% | -38.05K% | -3.59K% |
FCF Margin | 299.40% | -21.87K% | n/a | -20.21K% | -27.26K% | -2.23K% |
EBITDA Margin | 316.79% | -30.27K% | n/a | -20.42K% | -37.95K% | -3.59K% |
Add to Watchlist
Select watchlists to add or remove HELP